Prognostic implications of HPV and TP53 status in early-stage vulvar squamous cell carcinoma.
Molecular classification identifies clinically distinct subgroups within stage I vSCC and HPV-/p53mut tumors demonstrate inferior survival, higher recurrence risk, and increased groin failure.